Expansion of U.S. Testing capacity using coordination hubs. Hub - 1 west

Ended Other Transaction Agreement Awarded Last action

Contract number
W52P1J2192001
Awardee
Awarding agency
Obligated
$66,152,167

Award facts

Opportunity
Contract value 100% obligated
$66,152,166.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Shelton, CT 06484, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · The purpose of modification P00007 is to formally close-out the agreement. $0
Funding Only Action P00006 · The purpose of modification P00006 is to DE-obligate funding. -$45,191,000
Funding Only Action P00005 · The purpose of modification P00005 is to DE-obligate funds. -$45,481,800
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 · Testing -$26
Funding Only Action P00002 · OTA extension modification, POP end 31 december 2022 -$8
Other Administrative Action P00001 · Modification P00001 is to extend the period of performance end date from 24 november 2021 to 01 july 2022 at no additional cost to the government $0
Original award $156,825,000

About this award

Written by GovTribe AI ·

Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $66.2 million other transaction agreement by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to provide expansion of United States testing capacity using coordination hubs. Specifically, Hub 1 West will be established in Shelton, Connecticut under the contract running from May 2021 through December 2022. Key deliverables include coordinating COVID-19 testing to increase nationwide capacity. Funding stems from the Department of Defense through the Army for biological defense programs. No set aside designation or major subcontractors are indicated. This award advances the Defense Department's efforts to bolster domestic pandemic response infrastructure.

Quick answers

Who was awarded contract W52P1J2192001?

W52P1J2192001 was awarded to Revvity Health Sciences, Inc. by Department of the Army (Department of Defense) on May 25, 2021.

How much is contract W52P1J2192001 worth?

The government has obligated $66,152,167 on W52P1J2192001.

Which agency awarded contract W52P1J2192001?

Department of the Army (Department of Defense) awarded W52P1J2192001, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W52P1J2192001 competed?

The extent of competition for W52P1J2192001 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login